2-(Methylsulfanyl)-N-(prop-2-en-1-yl)thieno[3,2-d]pyrimidin-4-amine

Catalog No. :
ACFLMU687
CAS No. :
343374-12-9
Molecular Formula :
C10H11N3S2
Molecular Weight :
237.35

IUPAC Name:N-allyl-2-(methylthio)thieno[3,2-d]pyrimidin-4-amine

2-(Methylsulfanyl)-N-(prop-2-en-1-yl)thieno[3,2-d]pyrimidin-4-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$567.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Methylsulfanyl)-N-(prop-2-en-1-yl)thieno[3,2-d]pyrimidin-4-amine
IUPAC NameN-allyl-2-(methylthio)thieno[3,2-d]pyrimidin-4-amine
MDL No.MFCD01444001
Molecular FormulaC10H11N3S2
Molecular Weight237.35
SMILESC=CCNC1=C2C(C=CS2)=NC(SC)=N1
InChI KeySSGOTSODPASPPU-UHFFFAOYSA-N
Synonym2-(methylsulfanyl)-N-(prop-2-en-1-yl)thieno[3,2-d]pyrimidin-4-amine;N-ALLYL-N-[2-(METHYLSULFANYL)THIENO[3,2-D]PYRIMIDIN-4-YL]AMINE;N-ALLYL-2-(METHYLSULFANYL)THIENO[3,2-D]PYRIMIDIN-4-AMINE;Thieno[3,2-d]pyrimidin-4-amine, 2-(methylthio)-N-2-propen-1-yl-
CAS No.343374-12-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACFLMU687 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXLTP679 route compound structure diagram
    ACXLTP67910017-11-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFLMU687 route product structure diagram
    ACFLMU687343374-12-9
Inquiry

2. ACFLMU687 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFLMU687 route product structure diagram
    ACFLMU687343374-12-9
Inquiry

Comments (0)